Functional studies further suggested that elevated expression of HOXB13 is related to ER downregulation and, consequently, to TAM-resistance in ER+ cancers (32).Further research should explore whether HOX family members influence immune evasion and response to checkpoint inhibitors. The gene discussed is HOXB13; the disease is cancer.